supar
A prognostic biomarker of inflammation for health risk assessment and personalized care
LONGEVITY
Assesses inflammation-driven aging, determines biological age, and provides personalized preventive interventions with suPARnostic®.
Acute care
Increases triage accuracy, strengthens risk stratification, and supports clinical decision-making in hospitals and acute care with suPARnostic®.
Research use
Optimize patient selection and monitor intervention outcomes to improve the efficiency and accuracy of clinical trials with suPARnostic®.
suPAR
What is it?
suPAR is a protein present in the blood that reflects the level of activation of the immune system and the degree of chronic inflammation. The higher the value, the higher the inflammation in the body.
This biological marker is useful for:
Identificarea inflamației sistemice
Understanding the severity of chronic diseases
Estimating overall health risk
An optimal level of suPAR indicates a balanced immune system and a lower risk of disease.
suPAR
Key features of suPAR
Marker of systemic inflammation
Correlated with disease severity and prognosis
Involved in the occurrence of cardiovascular and renal diseases
It grows with age and with unhealthy lifestyle
Clinically validated in numerous studies
A high level of suPAR indicates an increased risk for health problems, but can be lowered through lifestyle changes and early medical intervention.
A low level is associated with good overall health.
suPAR
What level of suPAR is expected in an individual?
suPAR values naturally increase with age
Can be accelerated by lifestyle and chronic conditions
There are differences between men and women
With the help of the biological age algorithm ViroGates, suPAR can be used to estimate:
Biological age
Aging rate
Potential health risk
This provides doctors with a powerful tool for early detection of health problems and personalizing prevention and treatment recommendations.
FAQ's
A high level of suPAR indicates increased immune system activation and a higher risk for various chronic or acute conditions. Conversely, a low level is associated with good overall health and a favorable prognosis.
No. Unlike biomarkers such as C-reactive protein (CRP) or troponin, suPAR is not specific to a single disease. It is a nonspecific and prognostic biomarker, which means it provides an overview of the body's immune and inflammatory status.
An elevated level is associated with:
- systemic inflammation,
- higher risk of cardiovascular and kidney diseases,
- more severe evolution of acute diseases,
- increased short-term mortality.
A low level is an indicator of good health and a favorable prognosis.
Yes. Because it provides a global picture of inflammation and immune activation, suPAR can be used to:
- identifying people at high risk,
- guiding preventive interventions,
- monitoring the effect of treatments or lifestyle changes.
